Cannabis (or marihuana) is one of the most widely consumed psychoactive substances in the world. According to the United Nations World Drug Report, 183 million people, or 3.8% of the world’s population, used cannabis in 2014. Its cultivation was also reported by 129 countries. Cannabis is subject to the United Nations System for International Control of Narcotic Drugs and Psychotropic Substances (hereafter “drugs”) and is the most widely consumed of all the drugs. According to that control system, cannabis is among the substances with the strictest legal status; they are the most prohibited, supposedly because of the harm they cause and their lack of medical usefulness.
While in the Americas cannabis policy reform is taking off, Europe seems to be lagging behind. At the level of national governments denial of the changing policy landscape and inertia to act upon calls for change reigns. At the local level, however, disenchantment with the current cannabis regime gives rise to new idea.
The Czech drug-related legislation is quite extensive and includes laws as well as various by-laws. The most important feature of the Czech legislative system is that criminal law does not consider drug use to be a criminal offence. The new Czech Criminal Code introduced a brand-new significant feature into the Czech legal system – the differentiation between cannabis and other narcotic drugs and psychotropic substances.
The drug trade has increased globally in intensity and reach, and substance abuse in South Africa has escalated rapidly. Drug misuse is a major social, legal and public health challenge despite the war on drugs, in which the USA has a disproportionate influence. Why this lack of progress and what can be done about it?
This paper discusses the case for decriminalization of cannabis use, based on a careful weighting of the currently available evidence regarding advantages and risks of such a policy change. The issue of decriminalization is a response to the widespread use of cannabis in spite of its current illegal status; that is, as a consequence of the perceived ineffectiveness of the traditional prohibition of cannabis use.
Cannabis was condemned by the 1961 Single Convention on Narcotic Drugs as a psychoactive drug with “particularly dangerous properties” and hardly any therapeutic value. Ever since, an increasing number of countries have shown discomfort with the treaty regime’s strictures through soft defections, stretching its legal flexibility to sometimes questionable limits.
When you hear the phrase “cannabis advocate,” you might picture someone with wild hair and a Bob Marley T-shirt. But Gerald Murray is nothing like that. At a news conference on Tuesday morning, he was smartly groomed and wore a blazer.
Uruguay’s senate voted today (10 December) to approve the world’s first national legal framework regulating the cultivation, trade and consumption of cannabis for medical, industrial as well as recreational purposes.
This paper provides a framework for understanding what decriminalization means within the broader context of depenalization. To illustrate these concepts, it provides a detailed discussion of a range of depenalization policies observed in developed countries, highlighting for each country a distinct issue that influences how the policy is implemented and its potential impact.
The legal approach to coca has been one of the most challenging topics in the current international drug control system, due to the plant’s connection to both commercial cocaine and ancient Andean traditions. Yet it’s rare for a case related to the coca leaf to come before a European court, in a region where those traditions are rarely discussed.
Today, on the United Nations’ International Day Against Drug Abuse and Illicit Trafficking (26th June), governments around the world are commemorating their decades-long support of the global war on drugs.
How does national legislation in different EU member states compare and how effective is the adding of new psychoactive substances (NPS) to the existing schedules of drug laws versus legislative experimentation designing new schedules or applying controls under medicines or consumer protection regulations?